Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;93(9):1061-3.
doi: 10.1097/OPX.0000000000000932.

Understanding and Treating Myopia: What More We Need to Know and Future Research Priorities

Sally A McFadden  1
Affiliations
Review

Understanding and Treating Myopia: What More We Need to Know and Future Research Priorities

Sally A McFadden. Optom Vis Sci. 2016 Sep.

Abstract

Tantalizing treatment options to limit further global increases in the prevalence of myopia are emerging. However, to design more effective interventions, we still need to learn more about the underlying causes of myopia and the associated biological changes. Based on the outcomes of the 2015 International Myopia Conference, this short article summarizes what more we still need to discover and suggests possible priorities for future research.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Global numbers affected (grey bars) and percent prevalence (red lines) in the world population for A. Myopia, defined as ≤−0.500 DS, and B. High Myopia, defined as ≤−5.000 DS. Predicted data is based on a Comprehensive Meta-analysis of existing data. Adapted with permission from IMC 2015 presentation by P. Sankaridurg. Dotted lines show 95% confidence limits calculated in the meta-analysis of prevalence data, and includes uncertainty in future population projections as estimated by the high and low fertility population projections from United Nations data. For further details of methods see article by Brien Holden and colleagues.
See this image and copyright information in PMC

References

    1. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036–42. - PubMed
    1. Sankaridurg P, Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Wong TY, Naduvilath TJ, Resnikoff S. Special Session: Brien Holden Memorial Symposium. Global prevalence of myopia, high myopia and temporal trends from 2000 to 2050.. Presentation given at the 15th International Myopia Conference; Wenzhou, China. September 24-27, 2015.
    1. Wildsoet C. Final session. Is 'light' a panacea for myopia? Question 4: is there a role for drug—treatments in human myopia—prevention/control? [Schaeffel F: discussant].. Presentation given at the 15th International Myopia Conference; Wenzhou, China. September 24-27, 2015.
    1. Chia A, Chua WH, Wen L, Fong A, Goon YY, Tan D. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol. 2014;157:451–7. e1. - PubMed
    1. Atchison D. Final session. Is 'light' a panacea for myopia? Question 3: is there a role for lens—treatments in human myopia—prevention/control? [Troilo D, discussant].. Presentation given at the 15th International Myopia Conference; Wenzhou, China. September 24-27, 2015.